Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia. (2020)
Attributed to:
One Health Drivers of Antibacterial Resistance in Thailand
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.01524-19
PubMed Identifier: 31712205
Publication URI: http://europepmc.org/abstract/MED/31712205
Type: Journal Article/Review
Volume: 64
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 2
ISSN: 0066-4804